Affected Ovary Relative Volume: A Novel Sonographic Predictor of Ovarian Reserve in Patients with Unilateral Endometrioma-A Pilot Study.
antimüllerian hormone
antral follicle count
endometrioma
endometriosis
fertility
ovarian reserve
premature ovarian failure
ultrasonography
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
17 Dec 2020
17 Dec 2020
Historique:
received:
21
11
2020
revised:
02
12
2020
accepted:
11
12
2020
entrez:
22
12
2020
pubmed:
23
12
2020
medline:
23
12
2020
Statut:
epublish
Résumé
The assessment of ovarian reserve in the case of endometrioma is of pivotal importance for planning a tailored management. However, both the antral follicle count (AFC) and the antimüllerian hormone (AMH) dosage are subject to a fair degree of variability in ovarian endometriosis. This study aimed to identify a sonographic parameter of ovarian reserve that could implement current available markers in patients with unilateral endometrioma. Patients with unilateral endometrioma admitted to our Endometriosis Center between March 2018 and April 2019 were enrolled. Transvaginal ultrasonography for the evaluation of eight sonographic indicators and AMH level determination were performed. The relationship between AMH level and each indicator was assessed. Thirty-four women were included. There was a positive significant correlation between AMH level and the healthy ovary AFC (HO-AFC) ( AORV may be a useful tool to assess ovarian reserve in patients with unilateral endometrioma without previous surgery and to guide physicians in clinical management.
Sections du résumé
BACKGROUND
BACKGROUND
The assessment of ovarian reserve in the case of endometrioma is of pivotal importance for planning a tailored management. However, both the antral follicle count (AFC) and the antimüllerian hormone (AMH) dosage are subject to a fair degree of variability in ovarian endometriosis. This study aimed to identify a sonographic parameter of ovarian reserve that could implement current available markers in patients with unilateral endometrioma.
METHODS
METHODS
Patients with unilateral endometrioma admitted to our Endometriosis Center between March 2018 and April 2019 were enrolled. Transvaginal ultrasonography for the evaluation of eight sonographic indicators and AMH level determination were performed. The relationship between AMH level and each indicator was assessed.
RESULTS
RESULTS
Thirty-four women were included. There was a positive significant correlation between AMH level and the healthy ovary AFC (HO-AFC) (
CONCLUSION
CONCLUSIONS
AORV may be a useful tool to assess ovarian reserve in patients with unilateral endometrioma without previous surgery and to guide physicians in clinical management.
Identifiants
pubmed: 33348770
pii: jcm9124076
doi: 10.3390/jcm9124076
pmc: PMC7767191
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Hum Reprod Update. 2014 Jan-Feb;20(1):124-40
pubmed: 24077980
Fertil Steril. 2016 Jul;106(1):164-171.e1
pubmed: 27060727
Fertil Steril. 2018 Dec;110(7):1218-1226
pubmed: 30503109
Hum Reprod. 2013 Aug;28(8):2140-5
pubmed: 23624580
Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:102-110
pubmed: 29545114
Adv Clin Exp Med. 2020 May;29(5):615-622
pubmed: 32437595
Gynecol Endocrinol. 2019;35(sup1):24-26
pubmed: 31532315
Hum Reprod. 2014 Mar;29(3):400-12
pubmed: 24435778
Fertil Steril. 2014 Apr;101(4):1031-7
pubmed: 24502890
Hum Reprod Update. 2014 Sep-Oct;20(5):688-701
pubmed: 24821925
Hum Reprod. 2011 Jul;26(7):1616-24
pubmed: 21505041
Front Endocrinol (Lausanne). 2018 Nov 27;9:686
pubmed: 30542322
Fertil Steril. 2011 Sep;96(3):685-91
pubmed: 21802672
Hum Reprod. 2016 May;31(5):926-37
pubmed: 27008889
Obstet Gynecol. 1986 Mar;67(3):335-8
pubmed: 3945444
Fertil Steril. 2018 Oct;110(5):932-940.e1
pubmed: 30316440
Lancet. 2010 Aug 28;376(9742):730-8
pubmed: 20801404
Lancet. 2004 Nov 13-19;364(9447):1789-99
pubmed: 15541453
Hum Reprod Update. 2014 May-Jun;20(3):370-85
pubmed: 24430863
Hum Reprod Open. 2018 Sep 29;2018(4):hoy016
pubmed: 30895257
J Clin Endocrinol Metab. 2012 Sep;97(9):3146-54
pubmed: 22723324
Ultrasound Obstet Gynecol. 2015 Aug;46(2):239-42
pubmed: 25504940
J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):142-8
pubmed: 19249702
J Ovarian Res. 2014 Nov 26;7:108
pubmed: 25424986
Fertil Steril. 1999 Aug;72(2):310-5
pubmed: 10439002
Fertil Steril. 2010 Aug;94(3):1044-51
pubmed: 19589513
Hum Reprod. 2005 Nov;20(11):3000-7
pubmed: 16246860
Int J Endocrinol. 2013;2013:959487
pubmed: 24348558
Hum Reprod. 2014 May;29(5):1042-8
pubmed: 24626805
Fertil Steril. 2019 May;111(5):944-952.e1
pubmed: 30878253
Fertil Steril. 2018 Jul 1;110(1):122-127
pubmed: 29935810
Hum Reprod Update. 2015 Nov-Dec;21(6):809-25
pubmed: 26168799
J Ovarian Res. 2017 Jul 12;10(1):43
pubmed: 28701212
Hum Reprod. 2012 Nov;27(11):3294-303
pubmed: 22821432
Hum Reprod. 2015 Feb;30(2):299-307
pubmed: 25432923
Fertil Steril. 2011 Aug;96(2):459-63
pubmed: 21719005
Obstet Gynecol Int. 2012;2012:305025
pubmed: 22496698
Reprod Biomed Online. 2018 Nov;37(5):631-640
pubmed: 30241771
J Clin Endocrinol Metab. 2014 Mar;99(3):723-32
pubmed: 24423305
Hum Reprod. 2018 Sep 1;33(9):1602-1618
pubmed: 30052961
Hum Reprod. 2010 Oct;25(10):2597-604
pubmed: 20729237